Docking Simulation Analysis of Natural Ingredients as Anti Virus SARS-Cov-2 on Helicase Inhibitors
Nya Daniaty Malau, St. Fatimah Azahra
Asian Journal of Research in Computer Science · pp. 94–106 · Published 8 Nov 2022
10.9734/ajrcos/2022/v14i4294Abstract
Aims: To find active compounds from natural ingredients that have the potential to be antivirals of SARS-CoV-2. Study Design: Simulation research. Place and Duration of Study: Physics Laboratory, Department of Physics Education, Universitas Kristen Indonesia, between December 2021 and August 2022. Methodology: The method used is a computational simulation commonly known as docking simulation or molecular docking. There are several steps taken, namely ligand and receptor preparation, docking simulation and analysis of simulation results. Results: The results obtained were from 22 ligand compounds of natural material selected as helicase receptor inhibitors, 14 ligand compounds were found that met the requirements according to Lipinski's five rules, namely Emodin, Luteolin, Curcumin, Kaemferol, Quercetin, Myricetin, Scutellarein, 10-Gingerol, Shogaol, Mangostin, Piseatanol, Diallyl disulfide, Cyperotundone and Eugenol. Of the 14 ligand compounds simulated with helicase receptors, it turned out that 14 stable ligand compounds were used as helicase receptor inhibitors. However, among the 14 ligands, myricetin is the most stable ligand with the smallest Gibbs free energy value, which is -8.7 kcal/mol. Conclusion: An active ingredient compound has been found that has the potential as an antivirus sars-COV-2 in the Helicase receptor, Myricetin from clove plants (Syzygium aromaticum). These results can be used as a basis for drug development for the development of SARS-COV-2 antivirus in the future.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
25
Page views
0
PDF downloads
4
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.